Intrinsic PD-L1 promotes antitumor activity of CD8+ cytotoxic T lymphocytes via in cis interaction with CD80

Cancer Commun (Lond). 2022 Aug;42(8):784-788. doi: 10.1002/cac2.12337. Epub 2022 Jul 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • B7-1 Antigen
  • B7-H1 Antigen*
  • CD8-Positive T-Lymphocytes
  • Humans
  • T-Lymphocytes, Cytotoxic

Substances

  • Antineoplastic Agents
  • B7-1 Antigen
  • B7-H1 Antigen